VOI - Voice of Indonesia | RRI - Radio Republik Indonesia

photo : reuters 

China's Sinovac Biotech is starting Phase III trials of its potential coronavirus vaccine in Brazil, it said on Monday, becoming one of three companies to move into the late stages in the race to develop an inoculation against the disease. As stated by Reuters (07/7) it follows a fast-track approval for the trials by Brazilian regulators last week. Sinovac stated the study, which will be done in partnership with Brazilian vaccine producer the Instituto Butantan, would recruit nearly 9,000 healthcare professionals working in COVID-19 specialised facilities and start this month. AstraZeneca's experimental COVID-19 vaccine, developed by researchers at the University of Oxford, and China National Pharmaceutical Group (Sinopharm) are the only other candidates in late-stage Phase III trials. Moderna also plans to start its late-stage trial this month. Sinovac initiated the development of the vaccine candidate in late January and is preparing a coronavirus vaccine plant, which it hopes will be ready this year and capable of making up to 100 million shots a year//Reuters